Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Cross

Showing results (151-160 of 313) with videos related to

Pageof 32
Sort By:
Birth Defects Research. Part A, Clinical and Molecular Teratology|October 18, 2006
Problems in using birth certificate files in the capture-recapture model to estimate the completeness of case ascertainment in a population-based birth defects registry in New York StateYing Wang, Charlotte M Druschel, Philip K Cross, et al.
ACG Case Reports Journal|February 28, 2022
Isolated Gastritis Secondary to Immune Checkpoint Inhibitors Complicated by Superimposed Cytomegalovirus InfectionAnita H Nguyen, Babak Torabi Sagvand, Daniel G Hwang, et al.
Inflammatory Bowel Diseases|December 16, 2023
Factors Associated With Extraintestinal Manifestations of Inflammatory Bowel Disease in SPARC-IBDMadeline Alizadeh, Kiran Motwani, Bernadette C Siaton, et al.
Digestive Diseases and Sciences|September 7, 2020
Nonalcoholic Fatty Liver Disease Is Common in IBD Patients However Progression to Hepatic Fibrosis by Noninvasive Markers Is RareGabrielle Ritaccio, Gianna Stoleru, Ameer Abutaleb, et al.
Nanoimpact|May 13, 2022
Similarity assessment of metallic nanoparticles within a risk assessment framework: A case study on metallic nanoparticles and lettuceYuchao Song, Eric Bleeker, Richard K Cross, et al.
Gastroenterology & Hepatology|August 29, 2017
A Health Survey of Gastroenterologist Prescribing Practices of Adalimumab for Treatment of Crohn's Disease: Final ResultsSamantha Zullow, Mark H Flasar, Deborah Greenberg, et al.
Physiology & Behavior|August 20, 2021
Toxin-induced aversive context conditioning: Assessing active aversive behaviors conditioned to the context of an automated activity monitorMinakshi Doobay, Shelly K Cross-Mellor, Deanne T O Wah, et al.
Expert Review of Gastroenterology & Hepatology|May 26, 2025
The position of anti-tumor necrosis factor agents for the treatment of adult patients with Crohn's diseaseStephen B Hanauer, Byong Duk Ye, Raymond K Cross, et al.
Inflammatory Bowel Diseases|July 3, 2019
Gender Differences and Other Factors Associated with Weight Gain Following Initiation of Infliximab: A Post Hoc Analysis of Clinical TrialsKaci E Christian, Katharine M Russman, Dhyan P Rajan, et al.
Inflammatory Bowel Diseases|October 17, 2024
Predicting Outcomes in Hospitalized Patients With Acute Severe Ulcerative Colitis in a Prospective Multicenter CohortLara Chaaban, Benjamin Cohen, Raymond K Cross, et al.
Pageof 32

Showing results (151-160 of 313) with videos related to

Sort By:
Pageof 32
Birth Defects Research. Part A, Clinical and Molecular Teratology|October 18, 2006
Problems in using birth certificate files in the capture-recapture model to estimate the completeness of case ascertainment in a population-based birth defects registry in New York StateYing Wang, Charlotte M Druschel, Philip K Cross, et al.
ACG Case Reports Journal|February 28, 2022
Isolated Gastritis Secondary to Immune Checkpoint Inhibitors Complicated by Superimposed Cytomegalovirus InfectionAnita H Nguyen, Babak Torabi Sagvand, Daniel G Hwang, et al.
Inflammatory Bowel Diseases|December 16, 2023
Factors Associated With Extraintestinal Manifestations of Inflammatory Bowel Disease in SPARC-IBDMadeline Alizadeh, Kiran Motwani, Bernadette C Siaton, et al.
Digestive Diseases and Sciences|September 7, 2020
Nonalcoholic Fatty Liver Disease Is Common in IBD Patients However Progression to Hepatic Fibrosis by Noninvasive Markers Is RareGabrielle Ritaccio, Gianna Stoleru, Ameer Abutaleb, et al.
Nanoimpact|May 13, 2022
Similarity assessment of metallic nanoparticles within a risk assessment framework: A case study on metallic nanoparticles and lettuceYuchao Song, Eric Bleeker, Richard K Cross, et al.
Gastroenterology & Hepatology|August 29, 2017
A Health Survey of Gastroenterologist Prescribing Practices of Adalimumab for Treatment of Crohn's Disease: Final ResultsSamantha Zullow, Mark H Flasar, Deborah Greenberg, et al.
Physiology & Behavior|August 20, 2021
Toxin-induced aversive context conditioning: Assessing active aversive behaviors conditioned to the context of an automated activity monitorMinakshi Doobay, Shelly K Cross-Mellor, Deanne T O Wah, et al.
Expert Review of Gastroenterology & Hepatology|May 26, 2025
The position of anti-tumor necrosis factor agents for the treatment of adult patients with Crohn's diseaseStephen B Hanauer, Byong Duk Ye, Raymond K Cross, et al.
Inflammatory Bowel Diseases|July 3, 2019
Gender Differences and Other Factors Associated with Weight Gain Following Initiation of Infliximab: A Post Hoc Analysis of Clinical TrialsKaci E Christian, Katharine M Russman, Dhyan P Rajan, et al.
Inflammatory Bowel Diseases|October 17, 2024
Predicting Outcomes in Hospitalized Patients With Acute Severe Ulcerative Colitis in a Prospective Multicenter CohortLara Chaaban, Benjamin Cohen, Raymond K Cross, et al.
Pageof 32